Girl Dies in Experimental Brain CRISPR Trial in China
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Science magazine detailed the death of a six-year-old girl in China who received an experimental, brain-directed CRISPR therapy, in what STAT described as a "heart-wrenching" account
- STAT's The Readout biotech newsletter flagged the Science report alongside a separate FDA panel vote to let compounding pharmacies produce unregulated peptides, before breaking for the summer
Why it matters: The death of a six-year-old in an experimental brain-directed CRISPR trial in China gives bioethicists a rare, publicly documented fatality case, and STAT framed the Science report as raising ethics and oversight questions for gene-editing research worldwide.
